Studies indicate that immune regulatory molecules such as programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) correlate with unfavorable outcomes and immune tolerance by promoting regulatory T cell (Treg) activation in CRC and gastric cancer (114). The gene discussed is CD274; the disease is colorectal carcinoma.